Literature DB >> 12967731

Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus.

Tatsuya Morita1, You Tei, Satoshi Inoue.   

Abstract

The maintenance of intellectual activity is an important area in the "good death" concept. To clarify the communication capacity levels of terminally ill cancer patients in their final week, and to identify factors contributing to the development of communication capacity impairment and agitated delirium, a retrospective study was performed on 284 consecutive hospice inpatients. The data were collected by chart review, and two independent raters measured the degree of communication capacity and agitation in the last week, using multiple items from the Memorial Delirium Assessment Scale, the Communication Capacity Scale, and the Agitation Distress Scale. The percentages of patients who could achieve complex communication were 43%, 28%, and 13% at 5 days, 3 days, and 1 day before death, respectively. Agitated delirium was identified in 20%. Patients receiving opioids at a dose of > or =120 mg oral morphine equivalents/day one week before death were significantly unable to communicate clearly 3 days before death (0.48 [0.28-0.84], P=0.011). Male gender and the presence of icterus were identified as significant contributors to the development of agitated delirium (odds ratios [95% C.I.]=2.6 [1.4-5.0], P<0.01; 2.4 [1.3-4.4], P< 0.01). These findings demonstrate that communication capacity impairment and agitated delirium are frequently observed in terminally ill cancer patients, and are significantly correlated with a higher dose requirement of opioids and the presence of icterus. To explore the best management to maintain the intellectual activity of dying patients, research should focus on a homogeneous sample of patients receiving high-dose opioids and those with hepatic encephalopathy. In the meanwhile, clinicians should educate patients and family members about the nature of the dying process and help facilitate the completion of life purposes requiring complex mental activities before the latest stages of cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12967731     DOI: 10.1016/s0885-3924(03)00287-2

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  16 in total

1.  Nursing Support of Home Hospice Caregivers on the Day of Patient Death.

Authors:  Margaret F Clayton; Jennifer Hulett; Kirandeep Kaur; Maija Reblin; Andrew Wilson; Lee Ellington
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

2.  Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.

Authors:  David Hui; Allison De La Rosa; Annie Wilson; Thuc Nguyen; Jimin Wu; Marvin Delgado-Guay; Ahsan Azhar; Joseph Arthur; Daniel Epner; Ali Haider; Maxine De La Cruz; Yvonne Heung; Kimberson Tanco; Shalini Dalal; Akhila Reddy; Janet Williams; Sapna Amin; Terri S Armstrong; William Breitbart; Eduardo Bruera
Journal:  Lancet Oncol       Date:  2020-05-29       Impact factor: 41.316

3.  Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.

Authors:  Masanori Mori; Akemi Naito Shirado; Tatsuya Morita; Kenichiro Okamoto; Yoshinobu Matsuda; Yoshihisa Matsumoto; Hirohide Yamada; Hiroki Sakurai; Etsuko Aruga; Keisuke Kaneishi; Hiroaki Watanabe; Takashi Yamaguchi; Takuya Odagiri; Shuji Hiramoto; Hiroyuki Kohara; Naoki Matsuo; Hideki Katayama; Tomohiro Nishi; Takashi Matsui; Satoru Iwase
Journal:  Support Care Cancer       Date:  2016-11-29       Impact factor: 3.603

4.  Missed opportunities: use of an end-of-life symptom management order protocol among inpatients dying expected deaths.

Authors:  Anne M Walling; Susan L Ettner; Tod Barry; Myrtle C Yamamoto; Neil S Wenger
Journal:  J Palliat Med       Date:  2011-03-09       Impact factor: 2.947

Review 5.  Symptoms of and Palliative Treatment for Unresectable Skin Cancer.

Authors:  Hiroyuki Goto; Yoshio Kiyohara; Masahisa Shindo; Osamu Yamamoto
Journal:  Curr Treat Options Oncol       Date:  2019-03-27

6.  Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives.

Authors:  Lindsay A Dow; Robin K Matsuyama; V Ramakrishnan; Laura Kuhn; Elizabeth B Lamont; Laurel Lyckholm; Thomas J Smith
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

7.  Symptom Expression in the Last Seven Days of Life Among Cancer Patients Admitted to Acute Palliative Care Units.

Authors:  David Hui; Renata dos Santos; Gary B Chisholm; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2014-09-19       Impact factor: 3.612

8.  Symptom communication during critical illness: the impact of age, delirium, and delirium presentation.

Authors:  Judith A Tate; Susan Sereika; Dana Divirgilio; Marci Nilsen; Jill Demerci; Grace Campbell; Mary Beth Happ
Journal:  J Gerontol Nurs       Date:  2013-06-10       Impact factor: 1.254

Review 9.  The last days of life: symptom burden and impact on nutrition and hydration in cancer patients.

Authors:  David Hui; Rony Dev; Eduardo Bruera
Journal:  Curr Opin Support Palliat Care       Date:  2015-12       Impact factor: 2.302

10.  Clinical changes in terminally ill cancer patients and death within 48 h: when should we refer patients to a separate room?

Authors:  In Cheol Hwang; Hong Yup Ahn; Sang Min Park; Jae Yong Shim; Kyoung Kon Kim
Journal:  Support Care Cancer       Date:  2012-09-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.